Methotrexate Injection and Pacritinib: Interaction Details
- Methotrexate Injection
- OtrexupRasuvoReditrex +6 more
- Pacritinib
- Vonjo
Medically reviewed by Dr. Brian Staiger, PharmD, BCPS
Also reviewed by the HelloPharmacist Editorial Team Updated AI-assisted Details about this page
- Dr. Brian Staiger, PharmD, BCPS, is a clinical pharmacist and pharmacotherapy specialist.
- AI-assisted, written
- AI is used only to summarize verified clinical information, never the open internet.
- Editorial policy
- How we build our interaction pages →
- Our AI policy →
A close look at the Methotrexate Injection and Pacritinib interaction:
Methotrexate Injection
- Otrexup
- Rasuvo
- Reditrex
- Abitrexate
- Folex
- Mexate
- Xatmep
- Jylamvo
- Trexall
What Happens When You Take Methotrexate Injection With Pacritinib
What can happen when they are taken together (rated Major)
Increased exposure and an increased risk of BCRP substrate-related adverse reactions
Interaction Deep Dive
A note from Dr. Brian Staiger If you’re a patient, this deep dive may be too technical, or bore you (or both). Read the plain-language explanation →
Pacritinib inhibits BCRP, so giving it together with BCRP substrates can raise the exposure to those substrates and thereby increase the likelihood of adverse reactions caused by them. During with pacritinib, adverse reactions associated with the BCRP substrate should be monitored for more often, and a lower dose of the BCRP substrate may be considered. A drug interaction study found that pacritinib 200 mg twice daily given with rosuvastatin 5 mg increased rosuvastatin 1.80-fold and 2-fold.1
The Methotrexate Injection and Pacritinib Interaction, Explained
Pacritinib (Vonjo) can slow down a protein in your body called , which helps move certain drugs out of your cells and gut. Methotrexate is one of the drugs that uses this pathway. If the pathway is slowed, more methotrexate may stay in your body, which can raise the chance of side effects such as mouth sores, nausea, low blood counts, or liver and kidney strain.
The strongest data come from a different drug, rosuvastatin, which rose about 1.8-fold with pacritinib. So this is a probable effect, not a certain one. Please keep taking both as prescribed. Your care team can adjust your methotrexate dose and check on you more often. Tell your pharmacist or doctor about any new sores, fever, or unusual tiredness.
Mechanism: Pacritinib inhibits (ABCG2) efflux transport. Methotrexate is a BCRP , so exposure may increase. Neither drug is relevant here as a ; the direction is increased methotrexate exposure.
- Magnitude: Not quantified for methotrexate. With rosuvastatin 5 mg, pacritinib 200 mg BID raised 1.8-fold and 2-fold.
- Onset: Unspecified. Evidence: Probable. Severity: Major.
- Risks: Methotrexate toxicity (, mucositis, , ). Methotrexate has a , so small exposure changes matter.
- Management: Monitor more frequently for adverse reactions (such as CBC, and function) and consider reducing the methotrexate dose.
See the 1 reference behind this explanation ↓
From the HelloPharmacist Pharmacy Team
AI-assisted: written with AI from this pair’s record in our interaction database, and reviewed by the HelloPharmacist pharmacy team. Written .
How we build these pages · How we use AI · Our editorial policy
Why Methotrexate Injection and Pacritinib Interact
The likely mechanism
of -mediated efflux transport by pacritinib
How to Manage the Methotrexate Injection and Pacritinib Interaction
Your care team can manage this by watching you more closely and tailoring your methotrexate dose.
- Keep taking both medicines exactly as prescribed. Do not stop or change either one on your own.
- Expect your team to monitor you for methotrexate side effects more often. The methotrexate dose may need to be reduced and individualized.
- Contact your pharmacist or prescriber promptly about mouth sores, nausea or vomiting, fever, infection signs, unusual bruising or bleeding, or marked fatigue.
- Tell every provider you see that you take both drugs.
Management is individual — confirm any change with your pharmacist or prescriber.
Questions for Your Pharmacist
- Does my dose of Methotrexate Injection or Pacritinib need adjusting while I take them together?
- What symptoms should prompt me to call you or my prescriber right away?
- Does the timing of my doses matter for this combination?
- Is there another option that avoids this interaction?
Literature Reports
1 report from the published literature. Each one is headed by the title of the published study it comes from.
What these reports are. Short summaries of published evidence on this combination: clinical studies, case reports and, at times, the FDA prescribing information for one of the drugs. They support this interaction, but it does not rest on them alone. It can also rest on prescribing information not summarized here, or on what is expected from how these two drugs, and others in their drug classes, are known to work.
-
Report 1 · Study title
Prescribing information: VONJO oral capsules, pacritinib oral capsules
A drug interaction study found that giving pacritinib 200 mg twice daily together with rosuvastatin 5 mg raised the of rosuvastatin 1.80-fold and its 2-fold.1
Methotrexate Injection and Pacritinib: Common Questions
How serious is the Methotrexate Injection and Pacritinib interaction?
It is rated major. Potentially serious — often needs a change or close monitoring.
How is the Methotrexate Injection and Pacritinib interaction managed?
Your care team can manage this by watching you more closely and tailoring your methotrexate dose. Keep taking both medicines exactly as prescribed. Do not stop or change either one on your own. Expect your team to monitor you for methotrexate side effects more often. The methotrexate dose may need to be reduced and individualized. Contact your pharmacist or prescriber promptly about mouth sores, n… Management is individual — always follow your own care team's guidance.
How quickly could this interaction happen?
The documented onset is "unspecified". The timing of this interaction is not well characterized.
How strong is the evidence for this interaction?
The evidence is graded "probable". Good supporting evidence, though not definitively proven.
Ask About the Methotrexate Injection and Pacritinib Interaction
Ask in your own words about taking Methotrexate Injection and Pacritinib together. The answer comes from this page’s interaction record and both drugs’ own information.
This box answers questions about this one combination only. For anything else about either drug, open its drug information page or ask a pharmacist.
AI answers from this page’s record and both drugs’ information, never the open internet. AI can make mistakes, so always check with your doctor or pharmacist.
References (1)
- Product Information: VONJO(R) oral capsules, pacritinib oral capsules. CTI BioPharma Corp (per FDA), Seattle, WA, 2024. DailyMed
Other Serious Interactions of Methotrexate Injection and Pacritinib
Also serious with Methotrexate Injection
Also serious with Pacritinib
These Medications Also Interact With Supplements
Prescription drugs aren't the whole picture — herbal and dietary supplements can interact with them too. From the evidence-graded Natural Medicines database:
With Pacritinib
- GrapefruitMajor
- St. John's WortMajor
- Activated CharcoalMajor
- American HelleboreMajor
- ArsenicMajor
- CesiumMajor
- EphedraMajor
- Sida CordifoliaMajor
- + 155 more
Check everything you take with our drug–supplement interaction checker.
Still Have Questions About This Combination?
Every question gets a real answer from a licensed pharmacist — free, as soon as they can.
About This Library
Built in-house, documented one interaction at a time. Our interaction database is not a complete list of every known interaction: a combination that isn't listed here hasn't been documented by us yet, which never means it's safe. Checking everything you take at once? Ask your pharmacist to review your full medication list. How we build and review it →
What Each Rating Means
Severity Levels
- Contraindicated These should generally not be used together.
- Major Potentially serious — often needs a change or close monitoring. This interaction.
- Moderate Can be significant — usually manageable with monitoring.
- Minor Usually limited clinical impact.
Evidence Grades
- EstablishedWell documented — supported by controlled studies or strong clinical data.
- ProbableGood supporting evidence, though not definitively proven. This interaction.
- SuspectedSome evidence suggests this interaction, but it is not well established.
- PossibleLimited or conflicting evidence; the interaction may occur.
- TheoreticalExpected from how the drugs work, or from studies of similar drugs; this exact pair has little direct study.
How Soon It Shows
- RapidEffects can appear quickly, often within about 24 hours of combining the drugs.
- DelayedEffects tend to build up gradually over days to weeks.
- UnspecifiedThe timing of this interaction is not well characterized. This interaction.
Ratings come from the documented interaction literature and are reviewed by a pharmacist. They describe the documented risk of the combination, not what will necessarily happen to you — your dose, timing, and health picture all matter.